Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Ichikawa

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Journal of Gastroenterology and Hepatology|January 4, 2021
Geranylgeranylacetone decreases the production of hepatitis B virus-related antigen by comprehensive downregulation of mRNA transcription activityMasafumi Haraguchi, Satoshi Miuma, Kazuo Yamamoto, et al.
Molecular Medicine Reports|November 5, 2011
Insulin-induced mTOR activity exhibits anti-hepatitis C virus activityToru Muraoka, Tatsuki Ichikawa, Naota Taura, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 14, 2014
Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatmentKeiichi Hashiguchi, Fuminao Takeshima, Yuko Akazawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2014
Incidence of and risk factors for bile duct stones after living donor liver transplantation: An analysis of 100 patientsTakemasa Senoo, Tatsuki Ichikawa, Naota Taura, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 3, 2016
Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant SurvivalEmi Katsura, Tatsuki Ichikawa, Naota Taura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2009
Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis CHisamitsu Miyaaki, Tatsuki Ichikawa, Kazuhiko Nakao, et al.
Journal of Gastroenterology|April 22, 2009
Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantationSusumu Eguchi, Masaaki Hidaka, Tetsuo Tomonaga, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 2016
Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver TransplantationSatoshi Miuma, Tatsuki Ichikawa, Hisamitsu Miyaaki, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Treatment of Hepatitis C Virus Infection with Direct-acting Antiviral Agents Elevates the Serum Small-dense Low-density Lipoprotein Cholesterol LevelNaoyuki Hino, Ryu Sasaki, Youichi Takahashi, et al.
The American Journal of Case Reports|October 28, 2021
Hemodialysis Patient with Diffuse Liver Calcification After Septic ShockKanako Hayashi, Mineaki Kitamura, Hideshi Tomura, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Journal of Gastroenterology and Hepatology|January 4, 2021
Geranylgeranylacetone decreases the production of hepatitis B virus-related antigen by comprehensive downregulation of mRNA transcription activityMasafumi Haraguchi, Satoshi Miuma, Kazuo Yamamoto, et al.
Molecular Medicine Reports|November 5, 2011
Insulin-induced mTOR activity exhibits anti-hepatitis C virus activityToru Muraoka, Tatsuki Ichikawa, Naota Taura, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 14, 2014
Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatmentKeiichi Hashiguchi, Fuminao Takeshima, Yuko Akazawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2014
Incidence of and risk factors for bile duct stones after living donor liver transplantation: An analysis of 100 patientsTakemasa Senoo, Tatsuki Ichikawa, Naota Taura, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 3, 2016
Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant SurvivalEmi Katsura, Tatsuki Ichikawa, Naota Taura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2009
Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis CHisamitsu Miyaaki, Tatsuki Ichikawa, Kazuhiko Nakao, et al.
Journal of Gastroenterology|April 22, 2009
Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantationSusumu Eguchi, Masaaki Hidaka, Tetsuo Tomonaga, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 2016
Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver TransplantationSatoshi Miuma, Tatsuki Ichikawa, Hisamitsu Miyaaki, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Treatment of Hepatitis C Virus Infection with Direct-acting Antiviral Agents Elevates the Serum Small-dense Low-density Lipoprotein Cholesterol LevelNaoyuki Hino, Ryu Sasaki, Youichi Takahashi, et al.
The American Journal of Case Reports|October 28, 2021
Hemodialysis Patient with Diffuse Liver Calcification After Septic ShockKanako Hayashi, Mineaki Kitamura, Hideshi Tomura, et al.
Pageof 15